Central Pharmaceuticals (DHA:CENTRALPHL) Other Long-Term Liabilities : BDT39.75 Mil (As of Sep. 2022)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Other Long-Term Liabilities?

Central Pharmaceuticals's other long-term liabilities for the quarter that ended in Sep. 2022 was BDT39.75 Mil.

Central Pharmaceuticals's quarterly other long-term liabilities declined from Mar. 2022 (BDT41.08 Mil) to Jun. 2022 (BDT40.44 Mil) and declined from Jun. 2022 (BDT40.44 Mil) to Sep. 2022 (BDT39.75 Mil).

Central Pharmaceuticals's annual other long-term liabilities declined from Jun. 2021 (BDT43.17 Mil) to Jun. 2022 (BDT40.44 Mil) and declined from Jun. 2022 (BDT40.44 Mil) to Jun. 2023 (BDT36.36 Mil).

Central Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Central Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Other Long-Term Liabilities Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Central Pharmaceuticals Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Jun23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Central Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Central Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines